Plus Therapeutics | 8-K: Current report
Plus Therapeutics | 8-K: Current report
Plus Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Plus Therapeutics | 8-K: Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Plus Therapeutics | 10-K: Annual report
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Clowes Howard
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaFrance Norman D.
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HEDRICK MARC H
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sims Andrew John Hugh MacIntyre
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lenk Robert P
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director van Es-Johansson An
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hawkins Richard J
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Petersen Greg
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer HEDRICK MARC H
Plus Therapeutics | 424B3: Prospectus
Plus Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Plus Therapeutics | EFFECT: Others
Plus Therapeutics | 8-K: Current report
Plus Therapeutics | CORRESP: CORRESP
Plus Therapeutics | UPLOAD: Others
No Data